Call For Papers
The ICHMR aims to explore emerging trends and future directions in research and innovation. It provides a collaborative platform for researchers and professionals to share ideas that shape the future of their respective domains.
The conference highlights advancements in Hematology, encouraging innovative, solution-oriented research that addresses global challenges and technological evolution.
Authors are invited to submit papers addressing, but not limited to, the following areas:
- Novel therapies for hematologic malignancies
- Advances in cancer immunotherapy research
- Genetic profiling in cancer treatment
- Clinical trials in hematologic cancers
- Patient-centered care in oncology
- Biomarkers for cancer prognosis
- Ethical issues in cancer research
- Multidisciplinary approaches to cancer care
- Quality of life in cancer patients
- Emerging trends in leukemia treatment
- Role of precision medicine in oncology
- Pediatric hematologic malignancies research
- Impact of lifestyle on cancer outcomes
- Innovative drug delivery systems in oncology
- Challenges in cancer clinical trials
- Socioeconomic factors affecting cancer care
- Advances in stem cell transplantation
- Radiation therapy advancements for cancers
- Integrative approaches to cancer treatment
- Future directions in cancer research
Assessment
Submissions will be assessed for originality, innovation, and relevance. Accepted papers will be presented at the conference and considered for publication opportunities in reputed academic platforms.
Registration
Participants are requested to complete the registration process following acceptance of their paper. Registration ensures inclusion in the conference schedule and official records.
Publication
All accepted manuscripts will be eligible for publication consideration in conference proceedings and associated academic journals.